Regulations.gov document
Withdrawal Letter from Skadden, Arps, Slate, Meagher & Flom LLP on behalf of…
Other · FDA-2005-P-0316 · posted Aug 18, 2009
Key facts
| Document ID | FDA-2005-P-0316-0005 |
|---|---|
| Title | Withdrawal Letter from Skadden, Arps, Slate, Meagher & Flom LLP on behalf of GlaxoSmithKline (GSK) |
| Document type | Other |
| Subtype | Withdrawal |
| Agency | FDA |
| Docket | FDA-2005-P-0316 |
| Posted | Aug 18, 2009 |
| Comment period opens | Aug 18, 2009 |
At a glance
- None Public comments on this docket
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Regulations.gov documents
Regulations.gov holds the rulemaking and other documents federal agencies post for public comment. Only agency documents are published here; public submissions are not.
Source: Regulations.gov (U.S. General Services Administration eRulemaking Program) · Source date: